New bioactive compound for difficult-to-treat allergies
Thursday, 24 April 2025 () Irritable bowel syndrome, chronic itching, asthma and migraine are in many cases hard-to-treat conditions. They have in common that they are triggered by an excessive immune response -- which in severe cases can be life-threatening. A team of researchers has now identified a promising bioactive compound that could effectively reduce symptoms and slash fatality risk. The compound blocks a receptor on certain defense cells, thus preventing a derailed immune response.
Thursday, 24 April 2025 ()
